Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Journal of the American College of Cardiology|November 1, 1995
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary ArteriesG I Barbash, J Reiner, H D White, et al.European Heart Journal|March 1, 1995
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality TrialG I Barbash, H D White, M Modan, et al.Journal of the American College of Cardiology|December 31, 1997
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesK W Mahaffey, C B Granger, C A Toth, et al.Archives of Internal Medicine|October 10, 1994
Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality TrialG I Barbash, H D White, M Modan, et al.Circulation|January 1, 1993
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality TrialG I Barbash, H D White, M Modan, et al.The American Journal of Cardiology|March 12, 1999
Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarctionY Birnbaum, G S Wagner, G I Barbash, et al.Circulation|September 12, 2001
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trialsM P Hudson, C B Granger, E J Topol, et al.The American Journal of Cardiology|October 12, 2000
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarctionY Birnbaum, G S Wagner, K B Gates, et al.JAMA|May 24, 1995
Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesF Van de Werf, E J Topol, K L Lee, et al.The American Journal of Cardiology|October 26, 2001
Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogramY Birnbaum, S Goodman, A Barr, et al.Pageof 5